Aphria Inc. Announces Third Consecutive Quarter of Positive Adjusted EBITDA and a 46% Increase in Adult-Use Cannabis Revenue From Prior Quarter
Adjusted EBITDA from Cannabis Operations of $3.4 Million Increased 155% from Prior QuarterStrengthened Balance Sheet and Cash PositionReceived EU GMP compliance confirmation for ARA-Avanti Rx AnalyticsUpdates Fiscal Year 2020 Outlook LEAMINGTON, ON, Jan. 14, 2020 /PRNewswire/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today reported its results for the second quarter ended November 30, 2019. All amounts are expressed … Read more